Why Is Blueprint Medicines (BPMC) Down 11.4% Since Last Earnings Report?
nasdaq.com
news
2022-06-02 11:31:00

A month has gone by since the last earnings report for Blueprint Medicines (BPMC). Shares have lost about 11.4% in that time frame, underperforming the S&P 500.

Will the recent negative trend continue leading up to its next earnings release, or is Blueprint Medicines due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.

Blueprint Medicines' Q1 Loss in Line, Revenues Top Mark

Blueprint Medicines reported a loss of $1.
